Summary: This paper describes the development of an automated immunoturbidimetric assay for transferrin on a centrifugal analyser. Regression analysis of transferrin values measured immunoturbidimetrically demonstrates good agreement with data obtained by radial immunodiffusion (y = 0.997 + 0.024 g/l, r = 0.980, n = 50). The assay has a detection limit of 1.0 g/l and working ränge of approximately 1.0 to 6.0 g/l of transferrin. Day-to-day coefficient of Variation is less than 3.5%. Immunoturbidimetric transferrin (g/l) and total iron binding capacity values ( / ) were compared using an established total iron binding capacity method (y = 0.050 -0.030 g/l, r = 0.967, n = 50). Minimal interference was found for lipaemic, haemolysed or icteric samples. Transferrin reference values with a mean of 3.05 g/l and 95% limits from 2.45 to 3.65 g/l were derived using serum froin 300 apparently healthy subjects (150 males, 150 females). We conclude that the proposed transferrin method is more reliable and easier to perform than presently available total iron binding capacity methods.
Introduction
chemical (3) and radiometric methods (4) for measurt . t , , --, , ing total iron binding capacity has been disappointing In recent years, very rehabte methods have been de-in ^ ^ ^ han(Js of ouf most experienced staff . veloped for the measuremeiit of serum iron. The measurement of total iron binding capacity however, Transferrin, the main serum iron binding protein (5) , still presents many problems to the clinical biochem-has been measured by some laboratories äs an alist, and this is evidenced by poor precision and accu-ternative to total iron binding capacity in order to racy in quality assurance programmes (l, 2). In our eliminate technical problems associated with the satuown laboratory, long-term performance of both ration of transferrin and removal of excess iron (6) .
We investigated the use of a centrifugal analyser for measuring transferrin immunoturbidimetrically using a recently released Software Option for processing non-linear Standard curves. We report our attempts to establish a more reliable and less time-consuming substitute for total iron binding capacity assays.
Materials and Methods

Initial procedure
Transferrin was measured on Cobas Bio (Hoffmann-La R che, Basel, Switzerland) using an immunological transferrin procedure s recommended (Boehringer Mannheim GmbH Cat. No. 661040 -Tab. 1). Patient specimens, quality control materials, and a set of 5 transferrin Standards (Boehringer, Cat. No. 475785) were carefully diluted l in 11 prior to analysis by mixing 100 μΐ of sample with 1ml of 9 g/l NaCl using a Brand Diiuette model DL 2/0.1 (Rudolf Brand, Wertheim, W. Germany). Diluted Standards were reused for convenience and economy and were stable for 2 weeks at 4 °C. Fibrin deposition in patient samples was avoided by using serum instead of plasma.
Modified ^procedure
Four modifications were made to improve precision.
1. Anti-transferrin was added s a "start" reagent to samples pre-incubated with buffer in Cobas Bio instead of the recommended simultaneous addition of sample and anti-transferrin. The anti-transferrin was dissolved in 2 ml of buffer rather than 10ml for use s a "start reagent" and one fifth the volume was used for each assay (tab. 1).
2. Pre-dilution was changed from l in 11 to l in 21 (100 μΐ of sample + 2.0 ml of 9 g/l NaCl) to provide a bigger reserve of diluted Standards.
3. Cobas Bio sample volume was increased from 5 μΐ to 15 μΐ to compensate for the change in sample pre-dilution and to generate more reliable absorbance changes for low concentrations of transferrin.
4. An additional Standard with a transferrin concentration approximating the mid-point of the reference r nge was prepared from a 50: 50 mixture of pre-diluted Boehringer Standards 2 and 4. The Cobas Bio log-logit Standard curve was then defined using the maximum number of 6 Standards.
Comparative methods
A radial immunodiffusion method (Behring NOR Partigen Plate OUCK 02/03) was used s a comparative method for transferrin. Fifty patient samples were analysed by both methods. A total iron binding capacity method (7) involving the measurement of the iron concentration (R che Product No. 0710598) of iron-saturated serum from which excess iron had been removed by magnesium carbonate (R che Product N o. 0710075) was used for comparirig total iron binding capacity and immunoturbidimetric transfefrin concentrations on an additional 50 serum samples. Total iron binding capacity measure-m ents were also performed using Cobas Bio.
Precision studies
Within run and day-to-day precision was monitored using Omega l and 2 quality control materials (Hyland Diagnostics, Illinois, U. S. A.). These were diluted with each batch of serum samples prior to analysis on Cobas Bio. 
Reference values
Fifty blood specimens were collected from both males and females in age groups 20 -> 39, 40 -» 59, and pver 60 years. In total, 300 specimens were collected from apparently healthy individuals with haemoglobin > 1.86 mmol/1 (males) and 1.78 mmol/I (females). Transferrin reference values with 95% limits were established using the parametric Hoffman procedure (8) .
A non-parametric classification by age and sex was also derived (9).
Results and Discussion
Method development
Initial attempts to analyse transferrin on Cobas Bio s recommended by Boehringer were unsuccessful. Within-run imprecision was often greater than 5% and it was not unusual to obtain individual results more than 20% lower than expected; Falsely low results were invariably accompanied by falsely high initial absorbance readings 5 seconds after mixing sample with buffered antiserum. It was impossible to completely eliminate this problem, even when initial absorbance meas rements were delayed s long s 15 seconds, and by this time the reaction had progressed significantly. The mixing cycle was checked by a R che engineer and found to be performing to specifications, and the same problem was reproduced on another Instrument. We therefore decided to quantitate transferrin using a mode of analysis that enabled anti-transferrin to be added s a "start" reagent to samples which had been pre-mixed with buffer during an incubation phase. It was then possible to make a reliable sample blank absorbance measurement s well s monitor the complete reaction absorbance change. Precision improved substantially to that of conventional spectrophotometric assays and withinrotor CV was often less than 1% (tab. 2). Other modifications were then introduced to further improve the assay.
When the amount of sample added to the antiserum was increased by approximately 50%, better precision was obtained for both patient samples and Standard curves. More consistent Standard curves were also generated from run to run, and absorbance change doubled for low concentrations of transferrin where good precision is most difficult to obtain ( fig. 1 ). The reliability of the calibration procedure was further improved by using 6 Standards instead of 5. With these modifications, fewer iterations were needed to derive a log-logit Standard curve, and individual Standards showed very little deviation about the line of best fit. It was found that low concentration Standards react with anti-transferrin much more slowly than the high concentration Standards, and only the latter near end-point after a four minute reaction period. A comparison between Standard curves obtained at four minutes and ten minutes is shown in figure 1 . The two lowest Standards reach only 50% and 75% of the ten minute absorbance after four minutes, in comparison with 85% by the higher Standards. We elected to use a four minute reaction period to reduce analysis time, although longer times or less sample pre-dilution may be more appropriate when analysing mainly low concentration samples.
Immunoturbidimetric and radial immunodiffusion transferrin comparisons
The accuracy of the immunoturbidimetric transferrin assay was assessed by assaying 50 patient sera in duplicate by this method and also by a radial immunodiffusion method. Results are shown in figure 2. The following relationship between methods was established (concentrations in g/l):
Immunoturbidimetric transferrin = (0.997 χ radial immunodiffusion) + 0.024, r = 0.980, s y . x = 0.169.
Good agreement was found between individual results and no significant differences were found for visibly lipaemic, icteric or haemolysed samples.
Interference studies
Interference from haemoglobin and bilirabin was assessed by adding 100 μΐ of concentrated Solutions of haemolysate and bilirubin (Sigma 98 + %, catalogue number B 4126) to 10ml aliquots of a serum pool with an undetectable concentration of haemoglobin and a low concentration of bilirubin (< 10 μιηοΐ/ΐ). The serum pool was then adjusted with saline in the same ratio. Each sample was analysed in quadruplicate in ttie same run. No interference was detected from haemoglobin or bilirubin up to the highest concentrations of each substance tested, namely bilirubin, 600 μπιοΐ/ΐ and haemoglobin, 43 μιηοΐ/ΐ (appearance of gross haemolysis). Even at these concentrations of haemoglobin and bilirubin, the transferrin concentration was the same s the pool (3.26 ± 0,01 g/l, 95% confidence limits), thus demonstrating absence of interference.
Interference from lipaemia was assessed by measuring the transferrin concentration of a grossly lipaemic serum pool before and after ultracentrifugation to remove triglyceride rieh particles in a Beckman Airfuge (Beckman Instruments Incorporated, Palo Alto, CA 94304). The transferrin concentrations before and after ultracentrifugation were 3.00 ± 0.01 g/l and 3.08 ± 0.01 g/l respectively. The slightly lower concentration in the lipaemic sample is consistent with a dilution effect of lipid particles, s the sodium and Chloride concentrations were approximately 2% lower for this sample.
Immunoturbidimetric transferrin and total iron binding capacity comparisons
It has been suggested that transferrin can be converted to total iron binding capacity using the relationship total iron binding capacity (μπιοΐ/l) = transferrin (g/l) χ 22.75, based on a transferrin molecular weight of 88000 and a transferrin binding capacity of 2 mol of iron per mol of transferrin (10).
We checked this experimentally using a total iron binding capacity method in which excess iron is re- Using the same molecular weight of 88 000 for transferrin, this implies an approxiinate transferrin binding capacity of 1.8 mol of iron per mol of transferrin under the conditions used to measure total iron binding capacity in this assay. Transferrin can be converted to an approximate total iron binding capacity (μιηοΐ/ΐ) by multiplying transferrin (g/l) χ 20.2. The reliability of this conversion will depend on the methods used and the contribution to total iron binding capacity of proteins other than transferrin (11).
Linearity
Linearity was assessed by making serial dilutions of a serum pool with a high transferrin concentration. Linearity was acceptable over the r nge of Standards used to construct the non-linear calibration curve (l .0 -+, 6.0 g/l). Results above and below these limits are identified s outside the rangfe of the assay.
Detection limit
Detection limit was measured using the protocol recommended by the International Föderation of Clinical Chemistry for assessment of analytical methods for routine use (12) . At transferrin concentrations near zero, the Standard deviation was 0.36 and 0.40 g/l in two independent runs, giving a detection limit of 0.99 g/l. Thus below l .0 g/l, absorbance changes are too small for reliable transferrin measurements, and less dilute samples or larger sample volumes should be used.
Reference ränge
Transferrin reference values with a mean of 3.05 g/l and 95% limits from 2.45 to 3.65 g/l were derived using serum from 300 apparently healthy subjects (150 males, 150 females). Data was processed by the method of Hoffman (8) . A normal probability plot indicated a very small group of transferrin values from females in the 20 to 39 year age group and males over 60 years that did not belong to the main distribution of results (possibly due to latent iron deficiency or oestrogens).
An equivalent reference ränge was found for males and females (2.45 -3.65 g/l). A non-parametric summary (9) of all results according to age and sex is provided in table 3. This data should be interpreted with allowance made for the number of subjects (n = 50) in each group.
General comments
In routine use, the new assay is easy to perform, and 19 samples can be anälysed in approximately 30 minutes. In many instances, analysis time for the same number of total iron binding capacity measurements ön an Auto-Analyzef (3) was more than half a day due to Problems such äs drifting baselines, changing sensitivity, Fe(OH) 3 
Conclusions
In summary, we believe that the Cobas Bio centrifugal analyser is a useful Instrument for the immunoturbidimetric measurement of transferrin, provided absorbance measurements taken soon after the mixing cycle are not used for calculations. Antigen excess is not a problem in this assay (l 3). Initial problems may be related to small air bubbles generated in the mixing cycle in the buffered anti-transferrin reagent. We have observed that surfactant can cause falsely high absorbances immediately after the mixing cycle in conventional photometric assays (e. g. magnesium estimations using calmagite).
For routine diagnostic investigations, we now measure transferrin in place of total iron binding capacity. Although theoretical and experimental relationships can be used to convert one to the other, such conversions should be interpreted carefully due to iron binding proteins other than transferrin (5, 11) . Most investigations concerning transferrin have been related to haematopoiesis, nutrition, infection and cell proliferation and it has recently been suggested that low levels of transferrin may prejudice the success of bone marrow transplantation and major surgery (14, 15). We believe that the present assay is ideal for such investigations.
